Exogenous mitochondrial transfer alleviates neurodegeneration in Parkinson’s disease model by improving mitochondrial function
Mitochondrion · 2026
DOI: 10.1016/j.mito.2026.102111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mitochondrion, 2026. Verfasst von Yu Si und 13 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine & Tissue Engineering Research Center, Institute of Medical Innovation and Translation, the Affiliated Yixing Hospital of Jiangs…. Hauptthemen laut MEDLINE: Mitochondria, Parkinson Disease. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Science and Technology Bureau of Zhenjiang, Science and Technology Planning Social Development Project of Zhenjiang City, Jiangsu University.
Abstract (Originalsprache)
Parkinson's disease (PD) is the second most common neurodegenerative disorder related to mitochondrial dysfunction. Recent studies have reported that mitochondrial transfer between cells occurred naturally and was effective for alleviating mitochondrial dysfunction. In the current study, functional exogenous mitochondria (Mito) were extracted and administered to both in vitro and in vivo PD models, exploring the therapeutic effects of Mito on damaged neurons. It was observed that in the in vitro PD model, Mito improved cell morphology and increased cell viability from 25.06% to 42.44% (p < 0.001), while enhancing mitochondrial activity within the cells by a 201% increase in the JC-1 red/green fluorescence ratio (p = 0.02). Further analysis suggests that Mito's neuroprotective effects are potentially mediated via integrated modulation of neuroinflammation and ferroptosis pathways. The findings of the in vivo PD model showed that Mito improved motor coordination in the rotational test by 71% (p < 0.01) and ameliorated depression-like behavior demonstrating a 13.4% enhancement in Sucrose preference (p < 0.001), accompanied by histological evidence of neuroprotection observed in Nissl-stained brain sections and the significant recovery in mitochondrial function by 31.6% (p = 0.01). This study is the first to demonstrate that Mito can enter a PD cell model and rescue neuronal and mitochondrial damage in both in vivo and in vitro settings, with transcriptomic analysis revealing the involvement of key molecular pathways related to neuroinflammation and ferroptosis. This offers new insights and prospectus therapeutic strategies for PD as well as a foundation for future research in clinical medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Regenerative Medicine & Tissue Engineering Research Center, Institute of Medical Innovation and Translation, the Affiliated Yixing Hospital of Jiangsu University, Yixing 214200, China; Jiangsu Key Laboratory of Medical…
- Zhenjiang Blood Center, Zhenjiang 212000, China.
- Institute of Cerebrovascular Disease, The Affiliated People's Hospital, Jiangsu University, Zhenjiang 212002, China.
- Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, China; Institute of Cerebrovascular Disease, The Affiliated…
- Regenerative Medicine & Tissue Engineering Research Center, Institute of Medical Innovation and Translation, the Affiliated Yixing Hospital of Jiangsu University, Yixing 214200, China.
Förderung
- Science and Technology Bureau of Zhenjiang
- Science and Technology Planning Social Development Project of Zhenjiang City
- Jiangsu University
- Graduate Research and Innovation Projects of Jiangsu Province
Zitieren
APA
Si, Y., Hayat, M. A., Ni, Y., Zhang, J., Guo, T., Cao, Y., Hong, Y., Zuo, H., Sun, X., Li, Z., Chen, B., Wan, J., Wang, Y., & Hu, J. (2026). Exogenous mitochondrial transfer alleviates neurodegeneration in Parkinson’s disease model by improving mitochondrial function. Mitochondrion. https://doi.org/10.1016/j.mito.2026.102111
Vancouver
Si Y, Hayat MA, Ni Y, Zhang J, Guo T, Cao Y, et al. Exogenous mitochondrial transfer alleviates neurodegeneration in Parkinson’s disease model by improving mitochondrial function. Mitochondrion. 2026. doi:10.1016/j.mito.2026.102111
BibTeX
@article{Si2026,
author = {Si, Yu and Hayat, Muhammad Abid and Ni, Yingyin and Zhang, Jingwen and Guo, Tao and Cao, Yudie and Hong, Yancheng and Zuo, Hao and Sun, Xin and Li, Zheng and Chen, Bo and Wan, Jia and Wang, Yong and Hu, Jiabo},
title = {Exogenous mitochondrial transfer alleviates neurodegeneration in Parkinson’s disease model by improving mitochondrial function},
journal = {Mitochondrion},
year = {2026},
doi = {10.1016/j.mito.2026.102111}
}
EUVIMED